Entero Healthcare [ENTERO] vs NOVELIX [NOVELIX] Detailed Stock Comparison

Entero Healthcare

NSE
Loading...

NOVELIX

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Entero Healthcare wins in 12 metrics, NOVELIX wins in 6 metrics, with 0 ties. Entero Healthcare appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricEntero HealthcareNOVELIXBetter
P/E Ratio (TTM)48.2465.57Entero Healthcare
Price-to-Book Ratio2.862.27NOVELIX
Debt-to-Equity Ratio21.760.00NOVELIX
PEG Ratio1.26-0.54NOVELIX
EV/EBITDA25.3459.13Entero Healthcare
Profit Margin (TTM)1.90%1.04%Entero Healthcare
Operating Margin (TTM)2.94%0.76%Entero Healthcare
EBITDA Margin (TTM)2.94%0.76%Entero Healthcare
Return on Equity5.36%0.48%Entero Healthcare
Return on Assets (TTM)3.51%0.31%Entero Healthcare
Free Cash Flow (TTM)$-881.80M$-137.91MNOVELIX
1-Year Return-13.53%50.92%NOVELIX
Price-to-Sales Ratio (TTM)0.911.10Entero Healthcare
Enterprise Value$49.37B$457.83MEntero Healthcare
EV/Revenue Ratio0.910.87NOVELIX
Gross Profit Margin (TTM)9.94%2.56%Entero Healthcare
Revenue per Share (TTM)$1,242$48Entero Healthcare
Earnings per Share (Diluted)$23.51$0.61Entero Healthcare
Beta (Stock Volatility)N/A0.28N/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Entero Healthcare vs NOVELIX Stock Performance Analysis

Loading Price Chart...

Entero Healthcare
NOVELIX
Entero Healthcare Stock Overview | NOVELIX Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Entero Healthcare-0.59%3.19%-3.55%-5.33%0.08%-21.46%
NOVELIX0.40%-3.21%0.15%-13.62%50.92%50.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Entero Healthcare-13.53%-1.92%-1.92%-1.92%-1.92%-1.92%
NOVELIX50.92%50.92%50.92%50.92%50.92%50.92%

News Based Sentiment: Entero Healthcare vs NOVELIX

Entero Healthcare

News based Sentiment: MIXED

October presented a mixed bag for Entero Healthcare Solutions, with positive price movements and analyst upgrades offset by continued volatility, a 52-week low, and a recent divestiture. The company is clearly in a period of change, making this a significant month for investors to assess its future direction.

View Entero Healthcare News Sentiment Analysis

NOVELIX

News based Sentiment: MIXED

October saw significant price fluctuations for Novelix Pharmaceuticals, alongside mixed financial results (revenue growth but net loss) and a positive analyst rating. These developments create a mixed investment picture, suggesting both potential and risk for investors.

View NOVELIX News Sentiment Analysis

Performance & Financial Health Analysis: Entero Healthcare vs NOVELIX

MetricENTERONOVELIX
Market Information
Market Cap i₹49.35B₹595.80M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i197,9982,851
90 Day Avg. Volume i136,8744,037
Last Close₹1,127.50₹40.16
52 Week Range₹1,044.90 - ₹1,584.25₹24.15 - ₹52.79
% from 52W High-28.83%-23.92%
All-Time High₹1,584.25 (Nov 04, 2024)₹52.79 (Jul 15, 2025)
% from All-Time High-28.83%-23.92%
Growth Metrics
Quarterly Revenue Growth0.28%30.98%
Quarterly Earnings Growth0.38%36.18%
Financial Health
Profit Margin (TTM) i0.02%0.01%
Operating Margin (TTM) i0.03%0.01%
Return on Equity (TTM) i0.05%0.00%
Debt to Equity (MRQ) i21.760.00
Cash & Liquidity
Book Value per Share (MRQ)₹396.70₹17.59
Cash per Share (MRQ)₹73.09₹0.57
Operating Cash Flow (TTM) i₹-1,784,990,000₹-221,349,560
Levered Free Cash Flow (TTM) i₹948.20M₹845,200
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Entero Healthcare vs NOVELIX

MetricENTERONOVELIX
Price Ratios
P/E Ratio (TTM) i48.2465.57
Forward P/E i22.17N/A
PEG Ratio i1.26-0.54
Price to Sales (TTM) i0.911.10
Price to Book (MRQ) i2.862.27
Market Capitalization
Market Capitalization i₹49.35B₹595.80M
Enterprise Value i₹49.37B₹457.83M
Enterprise Value Metrics
Enterprise to Revenue i0.910.87
Enterprise to EBITDA i25.3459.13
Risk & Other Metrics
Beta iN/A0.28
Book Value per Share (MRQ) i₹396.70₹17.59

Financial Statements Comparison: Entero Healthcare vs NOVELIX

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ENTERONOVELIX
Revenue/Sales i₹14.04B₹223.51M
Cost of Goods Sold i₹12.64B₹217.79M
Gross Profit i₹1.40B₹5.73M
Research & Development iN/AN/A
Operating Income (EBIT) i₹412.02M₹1.69M
EBITDA i₹558.96M₹1.80M
Pre-Tax Income i₹363.63M₹1.69M
Income Tax i₹61.31M₹624,000
Net Income (Profit) i₹302.32M₹1.07M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ENTERONOVELIX
Cash & Equivalents i₹2.29B₹6.79M
Total Current Assets i₹20.76B₹269.33M
Total Current Liabilities i₹8.45B₹96.67M
Long-Term Debt i₹670.18M₹0
Total Shareholders Equity i₹17.70B₹175.39M
Retained Earnings i₹638.28M₹-18.76M
Property, Plant & Equipment i₹1.64B₹1.86M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ENTERONOVELIX
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricENTERONOVELIX
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i197,9982,851
Average Daily Volume (90 Day) i136,8744,037
Shares Outstanding i43.51M9.95M
Float Shares i11.24M3.12M
% Held by Insiders i0.63%0.82%
% Held by Institutions i0.20%0.00%

Dividend Analysis & Yield Comparison: Entero Healthcare vs NOVELIX

MetricENTERONOVELIX
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A